Abstract: The present invention relates to a method by use of a pharmaceutical composition for preventing or treating inflammatory disease, colorectal cancer and prostate cancer, which contains an A3 adenosine receptor agonist, 2-chloro-N6-(3-iodobenzyl)-4?-thioadenosine-5?-N-methyluronamide (thio-Cl-IB-MECA), N6-(3-iodobenzyl)-4?-thioadenosine-5?-N-methyluronamide (thio-IB-MECA), or a pharmaceutically acceptable salt thereof. The pharmaceutical composition of the invention is significantly less toxic than conventional A3 adenosine agonists, and thus is useful for prevention or treatment of inflammatory disease. In addition, it more selectively inhibits the growth of androgen receptor-dependent or independent prostate cancer cells than other A3 adenosine receptor agonists and thus is useful for prevention or treatment of colorectal cancer or prostate cancer.

Abstract: Pressure swing adsorption process for the separation of a feed gas mixture comprising (a) providing a pressure swing adsorption system comprising one or more composite beds, each composite bed comprising adsorbent material disposed in two or more vessels in parallel flow configuration, each vessel having a feed end and a product end; (b) performing cyclic sequential steps comprising adsorption/make product, withdrawing gas at decreasing pressure from the composite bed, purging the composite bed, and introducing gas into the composite bed at increasing pressure; and (c) for any of the sequential steps, setting a flow rate or flow rates of one or more gases selected from the group consisting of gas introduced into or withdrawn from the feed end or ends of any of the two or more vessels and gas introduced into or withdrawn from the product end or ends of any of the two or more vessels.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory disease, colorectal cancer and prostate cancer, which contains an A3 adenosine receptor agonist, 2-chloro-N6-(3-iodobenzyl)-4?-thioadenosine-5?-N-methyluronamide (thio-Cl-IB-MECA), N6-(3-iodobenzyl)-4?-thioadenosine-5?-N-methyluronamide (thio-IB-MECA), or a pharmaceutically acceptable salt thereof. The pharmaceutical composition of the invention is significantly less toxic than conventional A3 adenosine agonists, and thus is useful for prevention or treatment of inflammatory disease. In addition, it more selectively inhibits the growth of androgen receptor-dependent or independent prostate cancer cells than other A3 adenosine receptor agonists and thus is useful for prevention or treatment of colorectal cancer or prostate cancer.

Abstract: Pressure swing adsorption process for the separation of a feed gas mixture comprising (a) providing a pressure swing adsorption system comprising one or more composite beds, each composite bed comprising adsorbent material disposed in two or more vessels in parallel flow configuration, each vessel having a feed end and a product end; (b) performing cyclic sequential steps comprising adsorption/make product, withdrawing gas at decreasing pressure from the composite bed, purging the composite bed, and introducing gas into the composite bed at increasing pressure; and (c) for any of the sequential steps, setting a flow rate or flow rates of one or more gases selected from the group consisting of gas introduced into or withdrawn from the feed end or ends of any of the two or more vessels and gas introduced into or withdrawn from the product end or ends of any of the two or more vessels.

Abstract: Pressure swing adsorption process for the separation of a feed gas mixture comprising (a) providing a pressure swing adsorption system comprising one or more composite beds, each composite bed comprising adsorbent material disposed in two or more vessels in parallel flow configuration, each vessel having a feed end and a product end; (b) performing cyclic sequential steps comprising adsorption/make product, withdrawing gas at decreasing pressure from the composite bed, purging the composite bed, and introducing gas into the composite bed at increasing pressure; and (c) for any of the sequential steps, setting a flow rate or flow rates of one or more gases selected from the group consisting of gas introduced into or withdrawn from the feed end or ends of any of the two or more vessels and gas introduced into or withdrawn from the product end or ends of any of the two or more vessels.

Abstract: A plasma display panel is disclosed. The plasma display panel includes a front substrate on which first and second electrodes are formed in parallel to each other, a rear substrate on which a third electrode is formed to intersect the first and second electrodes, and a barrier rib, formed between the front and rear substrates. At least one of the first electrode or the second electrode is formed in the form of a single layer. At least one of the first electrode or the second electrode has a portion with the curvature.

Abstract: A plasma display panel is disclosed. The plasma display panel includes a front substrate including a first electrode and a second electrode, a rear substrate including a third electrode, and a barrier rib formed between the front and rear substrates. At least one of the first electrode or the second electrode is formed in the form of a single layer. At least one of the first electrode or the second electrode includes at least one line portion intersecting the third electrode, and a plurality of projecting portions projecting from at least one line portion. The shape of at least one of the plurality of projecting portions is different from the shape of the other projecting portions.

Abstract: A plasma display panel according to an aspect of the present invention includes a scan electrode and a sustain electrode formed on an upper substrate in parallel with each other, a first barrier rib formed on a lower substrate opposing the upper substrate in parallel with the scan electrode, and a second barrier rib formed in the direction intersecting the first barrier rib, wherein the scan electrode or the sustain electrode comprises at least two or more bus electrodes, at least one of the bus electrodes is formed to be superposed onto the first barrier rib. Therefore, there is an advantage that the brightness is increased, since the area of portions of the bus electrode formed on the discharge space is small and thus the aperture ratio is raised. In addition, the boundary image sticking phenomenon and luminescent spot phenomenon in the non-discharge cell by cross-talk with neighboring cells can be reduced, since the area of portions of the electrode superposed onto the first barrier rib is also decreased.

Abstract: The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the synthesis of indirubin derivative known as CDK(Cyclin-dependent kinase) inhibitor. Further, inhibition activity of proliferation as to human cancer cell line and apoptosis against induced-differentiation of said indirubin derivative are researched to develop a novel indirubin derivative having efficacious anticancer properties as to various human cell lines.

Abstract: A method and apparatus for producing high purity argon by combined cryogenic distillation and adsorption technologies is disclosed. Crude argon from a distillation column or a so-called argon column is passed to a system of adsorption vessels for further purification. Depressurization gas from adsorption is introduced back, in a controlled manner, to the distillation column and/or a compressor or other means for increasing pressure. Particulate filtration and getter purification may optionally be used.

Abstract: The present invention relates to a plasma display panel and method for manufacturing the same in which electron discharge characteristic is improved and a voltage margin can be secured. According to a first embodiment of the present invention, a plasma display panel including a plurality of a pair of display electrodes formed and arranged parallely on an upper plate, a plurality of address electrodes formed on a lower plate and arranged to be crossed to the display electrodes, a barrier rib defined a discharge space on the lower plate, and fluorescent body formed between the barrier ribs, includes further: a number of discharge cells having the discharge space; and an alkali metal layer formed in the discharge cells for supplying electrons to the discharge space.

Abstract: The present invention relates to nucleoside derivatives represented by general formulas I and II, their synthetic methods and their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.

Abstract: A plasma display panel is disclosed. The plasma display panel includes a front substrate including a first electrode and a second electrode, a rear substrate including a third electrode, and a barrier rib formed between the front and rear substrates. At least one of the first electrode or the second electrode is formed in the form of a single layer. At least one of the first electrode or the second electrode includes at least one line portion intersecting the third electrode, and a plurality of projecting portions projecting from at least one line portion. The shape of at least one of the plurality of projecting portions is different from the shape of the other projecting portions.

Abstract: A plasma display panel is disclosed. The plasma display panel includes a front substrate on which first and second electrodes are formed in parallel to each other, a rear substrate on which a third electrode is formed to intersect the first and second electrodes, and a barrier rib, formed between the front and rear substrates. At least one of the first electrode or the second electrode is formed in the form of a single layer. At least one of the first electrode or the second electrode has a portion with the curvature.

Abstract: Pressure swing adsorption process for the separation of a feed gas mixture comprising (a) providing a pressure swing adsorption system comprising one or more composite beds, each composite bed comprising adsorbent material disposed in two or more vessels in parallel flow configuration, each vessel having a feed end and a product end; (b) performing cyclic sequential steps comprising adsorption/make product, withdrawing gas at decreasing pressure from the composite bed, purging the composite bed, and introducing gas into the composite bed at increasing pressure; and (c) for any of the sequential steps, setting a flow rate or flow rates of one or more gases selected from the group consisting of gas introduced into or withdrawn from the feed end or ends of any of the two or more vessels and gas introduced into or withdrawn from the product end or ends of any of the two or more vessels.

Abstract: A plasma display panel is provided which evenly deposits a phosphorus layer by forming a buffer layer before forming the phosphorus layer within a discharge cell of a rear surface substrate. The plasma display panel includes a front substrate on which are formed common sustain electrode and scan sustain electrodes and through which light is emitted and a rear substrate on which discharge cells are formed by barrier ribs and address electrodes. The rear substrate may be bonded to the front substrate by frit glass.

Abstract: The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the synthesis of indirubin derivative known as CDK(Cyclin-dependent kinase) inhibitor. Further, inhibition activity of proliferation as to human cancer cell line and apoptosis against induced-differentiation of said indirubin derivative are researched to develop a novel indirubin derivative having efficacious anticancer properties as to various human cell lines.

Abstract: The present invention relates to 1-/2-substituted-1H/-2H-[1,2,3]triazolo[4,5-g]phthalazine-4,9-dione compounds and their pharmaceutically acceptable salts, a process for preparing the compounds and a pharmaceutical composition comprising the compounds. The compounds are shown to effectively inhibit cell proliferation and are thus expected to be used for treatment or prevention or treatment of various cancers or as an ancillary(auxiliary) means of the same.

Abstract: The present invention relates to a pharmaceutical composition preventing cancer and treating cancer and inflammation, which is characterized in that including xanthorrhizol as an active principle. Xanthorrhizol not only inhibits mutagenesis and tumor formation, and enhances the activity of detoxification enzyme of carcinogen, induces apoptosis of cancer cell, and suppresses the activity of COX-2 and iNOS which are related to tumor promotion and inflammatory reaction. Thus, a pharmaceutical composition including xanthorrhizol can be utilized for prevention of cancer and treatment of cancer and inflammation.

Abstract: A pressure swing adsorption process for recovering a less readily adsorbable component from a feed gas mixture comprising at least one less readily adsorbable component and at least one more readily adsorbable component. The process utilizes a plurality of adsorbent beds, each bed having a feed end and product end, wherein the process includes the gas transfer steps of (1) transferring gas from the product end of the bed to the product end of another bed; followed by (2) withdrawing waste depressurization gas from the feed end of the bed while continuing to transfer gas from the product end of the bed to the product end of another bed; (3) during either or both of (1) and (2), transferring gas from the feed end of the bed to the feed end or ends of the one or more other beds; and (4) prior to (1), transferring gas from the product end of the bed at a higher pressure to the product end of another bed at a lower pressure.